Gender Differences in the Relationships Between Plasma Plasminogen Activator Inhibitor-1 Activity and Factors Linked to the Insulin Resistance Syndrome in Essential Hypertension
- 1 March 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (3) , 553-559
- https://doi.org/10.1161/01.atv.17.3.553
Abstract
Abstract Impaired fibrinolysis due to elevated levels of plasma plasminogen activator inhibitor type 1 (PAI-1) is a risk factor for thromboembolic disease. Hypertension, obesity, derangements in lipid and glucose homeostasis, and elevated levels of PAI-1 are features of the insulin resistance syndrome. The interrelationships between PAI-1 and the metabolic disturbances seen in this condition are unsettled. We investigated the associations between PAI-1 activity and components of the insulin resistance syndrome in 53 men and 31 women with untreated hypertension. In men, PAI-1 activity correlated significantly with plasma glucose ( r =.41, P =.002), insulin sensitivity ( r =−.35, P =.01), and insulin-induced suppression of nonesterified fatty acid (NEFA) ( r =−.43, P =.007). Plasma glucose and NEFA suppression were independently associated with PAI-1 activity in a multivariate analysis. In women, PAI-1 activity correlated with body mass index ( r =.62, P =.0005), waist-to-hip ratio ( r =.75, P =.0001), plasma glucose ( r =.50, P =.007), insulin ( r =.49, P =.009), proinsulin ( r =.57, P =.002), C-peptide ( r =.60, P =.0009), insulin sensitivity ( r =−.74, P =.0001), NEFA suppression ( r =−.64, P =.003), and triglycerides ( r =.58, P =.001). In multivariate analyses, insulin sensitivity and NEFA suppression were independently associated with PAI-1 if waist-to-hip ratio was not included in the model. After introduction of waist-to-hip ratio into the model, waist-to-hip ratio was the only independent predictor of PAI-1 activity. We conclude that in women, waist-to-hip ratio, body mass index, and insulin-induced NEFA suppression are determinants for PAI-1 activity. In men, insulin-induced NEFA suppression and plasma glucose are independently associated with PAI-1 activity.Keywords
This publication has 37 references indexed in Scilit:
- Hyperproinsulinemia of Type II Diabetes Is Not Present Before the Development of HyperglycemiaDiabetes Care, 1994
- Basal plasma concentration of tissue plasminogen activator (t-PA) and the adaption to strenuous exercise in familial hypercholesterolaemia (FH)Blood Coagulation & Fibrinolysis, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1The American Journal of Cardiology, 1993
- Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.Journal of Clinical Investigation, 1993
- Impaired fibrinolysis and risk of thromboembolismProgress in Cardiovascular Diseases, 1991
- Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart diseaseAmerican Heart Journal, 1991
- Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in HypertensionNew England Journal of Medicine, 1990
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963